Global Health Limited , the company behind the renowned Medanta chain of hospitals, has taken a significant step towards expanding its presence in Northeast India. The company recently received in-principle approval from the Assam Industrial Development Corporation Limited (AIDCL) for the allotment of land in Guwahati, Assam, paving the way for a new hospital project.

Land Allotment Details

The approval letter confirms the allotment of 3.5 acres (14,164.50 square meters) of land to Global Health Limited. The site is strategically located at the Industrial Estate in Sarusajai, Guwahati, positioning the future hospital in a developing area of the city.

Terms of Allotment

The land has been allotted for an initial period of 60 years, with the possibility of a 30-year extension. This long-term arrangement provides Global Health Limited with a stable foundation for its expansion plans in the region.

Financial Commitment

As part of the approval process, Global Health Limited has already demonstrated its commitment to the project by paying 10% of the total land cost as application money. The company now has a three-month window to comply with additional conditions, including the payment of the remaining amount.

Next Steps

In a disclosure to the stock exchanges, Global Health Limited stated that its management is actively working on the next steps for the project. Rahul Ranjan, Company Secretary & Compliance Officer, assured investors that the company would keep the exchanges and stakeholders updated on any material developments regarding the proposed hospital.

Implications for Healthcare in Assam

This move by Global Health Limited signifies a potential boost to the healthcare infrastructure in Guwahati and the surrounding regions. The establishment of a Medanta hospital could bring advanced medical facilities and expertise to Northeast India, potentially improving healthcare access for the local population.

Investor Outlook

While the company has not disclosed specific details about the proposed hospital's capacity or investment value, the land acquisition marks a concrete step in Global Health Limited's expansion strategy. Investors and market watchers will likely keep a close eye on further announcements regarding the project's timeline, scope, and potential impact on the company's future growth.

Global Health Limited continues to demonstrate its commitment to expanding its healthcare network across India. As the project develops, it may present opportunities for enhanced healthcare services in the region and potential long-term value creation for the company's stakeholders.

Global Health Limited , operating under the brand name Medanta, has reported strong financial results for the first quarter of fiscal year 2026, demonstrating significant growth across key metrics.

Financial Highlights

Medanta's total income for Q1 FY2026 reached INR 10,513.00 million, marking a substantial 19% year-on-year increase from INR 8,830.00 million in the same quarter last year. The company's EBITDA saw an impressive 23% growth, reaching INR 2,553.00 million, with an improved EBITDA margin of 24.30%.

One of the standout figures was the company's profit after tax (PAT), which surged by 50% to INR 1,590.00 million. The PAT margin also saw a notable improvement, rising to 15.10% from 12.00% in the corresponding quarter of the previous year.

Operational Performance

The company's operational metrics showed robust growth:

• Inpatient volumes increased by 14%
• Outpatient volumes grew by 13%
• Average occupied bed days rose by 13%
• Overall occupancy reached approximately 63% on increased bed capacity

The average revenue per occupied bed (ARPOB) for the quarter stood at INR 66,584.00, up 4% from INR 64,035.00 in Q1 FY2025.

International Patient Revenue

Medanta reported a significant 34% year-on-year increase in revenue from international patients, reaching INR 636.00 million for the quarter.

Expansion and Growth Initiatives

The company has made notable strides in its expansion plans:

• Operationalized a new 110-bed hospital in Ranchi in July 2025
• Poised to commence operations at the 550-bed Medanta Noida facility in the coming weeks
• Plans to add 2,000 beds over the next 3-4 years, with 1,000 beds in the near term

Mature vs. Developing Hospitals Performance

Mature Hospitals

Mature hospitals, primarily the Gurugram facility, saw an 11% year-on-year growth in total income, reaching INR 7,006.00 million. The EBITDA for mature hospitals grew by 7% to INR 1,640.00 million, with a margin of 23.40%.

Developing Hospitals

Developing hospitals, comprising Lucknow and Patna, demonstrated strong momentum with a 36% year-on-year growth in total income, reaching INR 3,219.00 million. EBITDA for these hospitals surged by 60% to INR 942.00 million, maintaining robust margins at 29.30%.

Management Commentary

Dr. Naresh Trehan, Chairman and Managing Director of Global Health Limited, emphasized the company's focus on delivering world-class, patient-centric care. He highlighted the onboarding of over 150 doctors, including 30 senior clinicians, to strengthen the medical team across specialties.

Pankaj Sahni, Group CEO, attributed the strong performance to the company's integrated care model and disciplined execution. He noted the significant growth in patient volumes and improved realizations, especially in the Gurugram unit.

Future Outlook

With the imminent launch of the Noida facility and ongoing expansion plans, Medanta is well-positioned for sustained growth. The company's focus on clinical excellence, operational efficiency, and strategic expansion initiatives suggests a positive outlook for the coming quarters.

As Global Health continues to strengthen its presence in key markets and enhance its medical capabilities, it remains committed to delivering high-quality healthcare services while driving financial growth.